Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$0.97 - $1.32 $33,673 - $45,823
-34,715 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$1.24 - $3.3 $112 - $300
91 Added 0.26%
34,715 $44,000
Q4 2020

Feb 12, 2021

SELL
$1.61 - $2.23 $1,598 - $2,214
-993 Reduced 2.79%
34,624 $67,000
Q3 2020

Nov 04, 2020

BUY
$1.71 - $2.51 $25,930 - $38,061
15,164 Added 74.14%
35,617 $89,000
Q2 2020

Aug 12, 2020

BUY
$1.77 - $4.23 $36,201 - $86,516
20,453 New
20,453 $45,000

About SOLENO THERAPEUTICS INC


  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $375M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.